Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117

Mikkael A. Sekeres, MD MS, Megan Othus, PhD, Alan F. List, MD, Olatoyosi Odenike, MD, Richard M. Stone, MD, Steven D. Gore, MD, Mark R. Litzow, MD, Rena Buckstein, MD, Mario r Velasco, MD, Rakesh Gaur, MD, Ehab Atallah, MD, Eyal Attar, MD, Frederick R. Appelbaum, MD, Harry P. Erba, MD PhD

Blood (2014) 124 (21): LBA-5.

https://doi.org/10.1182/blood.V124.21.LBA-5.LBA-5

Published: 2014

Journal Articles

Dasatinib Has Activity in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL/SLL), a Phase II Trial

Philip C. Amrein, MD, Eyal Attar, MD, Tak Takvorian, M.D., Ephraim Hochberg, Karen K. Ballen, MD, Kathleen M. Leahy, Donna Neuberg, ScD, Jennifer R. Brown, MD, PhD

Blood (2008) 112 (11): 3162.

https://doi.org/10.1182/blood.V112.11.3162.3162

Published: 2008

Journal Articles

Development of CMV-SPECIFIC Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of NAÏVE CD8+ T Cells

Blood (2008) 112 (11): 1167.

https://doi.org/10.1182/blood.V112.11.1167.1167

Published: 2008

Journal Articles

Restoration of Bone Balance Via Activin a Inhibition Results in Anti-Myeloma Activity

Blood (2008) 112 (11): 645.

https://doi.org/10.1182/blood.V112.11.645.645

Published: 2008

Journal Articles

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Meghan Delaney, DO, Beow Yeap, Sc.D, Richard L. Haspel, MD, PhD, Thomas R. Spitzer, MD, Steven L. McAfee, MD, Bimalangshu Dey, MD, PhD, Eyal Attar, MD, Grace Kao, MD, Edwin Alyea, MD, Stephanie Lee, MD, Corey Cutler, MD, Vincent Ho, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Ballen Karen, MD

Blood (2007) 110 (11): 2032.

https://doi.org/10.1182/blood.V110.11.2032.2032

Published: 2007

Journal Articles

Cardiac Transplant Followed by High-Dose Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients with AL Amyloidosis and Severe Heart Failure.

Bimalangshu R. Dey, MD, PhD, Thomas R. Spitzer, MD, Thomas E. MacGillivray, MD, Stephen S. Chung, MD, G.W. Dec, MD, David C. Seldin, MD, Steven L. McAfee, MD, Karen Ballen, MD, Eyal Attar, MD, Martha Skinner, MD, Joren C. Madsen, MD, DPhil, Marc J. Semigran, MD

Blood (2007) 110 (11): 732.

https://doi.org/10.1182/blood.V110.11.732.732

Published: 2007

Journal Articles

Identification of RPS14 as the 5q-Syndrome Gene by RNA Interference Screen.

Benjamin L. Ebert, MD, PhD, Jennifer Pretz, Jocelyn Bosco, Cindy Y. Chang, Pablo Tamayo, PhD, Naomi Galili, PhD, Azra Raza, MD, David Root, PhD, Eyal Attar, MD, Steven R. Ellis, PhD, Todd R. Golub, MD

Blood (2007) 110 (11): 1.

https://doi.org/10.1182/blood.V110.11.1.1

Published: 2007

Journal Articles

The Type of Upfront Induction Therapy for Newly Diagnosed Multiple Myeloma Patients Has No Significant Impact on Clinical Outcomes after Autologous Hematopoietic Stem Cell Transplantation.

Stephen S. Chung, MD, Thomas R. Spitzer, MD, David T. Ting, MD, Christine Dube, Andrew J. Yee, MD, Karen Ballen, MD, Steven L. McAfee, MD, Eyal Attar, MD, Bimalangshu R. Dey, MD, PhD

Blood (2007) 110 (11): 5128.

https://doi.org/10.1182/blood.V110.11.5128.5128

Published: 2007

Journal Articles

Non-Myeloablative T-Cell Depleted (TCD) Haploidentical Hematopoietic Cell Transplantation (HCT) Followed by Donor Leukocyte Infusion(s) for Hematologic Malignancies: The MGH Experience.

Bimalangshu R. Dey, MD, PhD, Andrew J. Yee, MD, Steven McAfee, MD, Christine Dube, Karen Ballen, MD, Eyal Attar, MD, Christine Colby, Susan Saidman, PhD, Karen Malikowski, Frederic Preffer, PhD, Megan Sykes, MD, Thomas R. Spitzer, MD

Blood (2007) 110 (11): 5088.

https://doi.org/10.1182/blood.V110.11.5088.5088

Published: 2007

Journal Articles

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

Julia Brown, PhD, Karen Ballen, MD, Sean McDonough, Xupeng Ge, MD, PhD, Kristen Stevenson, PhD, Haesook Kim, PhD, Carol Reynolds, Bimalangshu R. Dey, MD, PhD, Steve McAfee, MD, Eyal Attar, MD, Thomas Spitzer, MD, Corey Cutler, MD, Vincent Ho, MD, Edwin Alyea, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD, Vassiliki A. Boussiotis, MD, PhD

Blood (2007) 110 (11): 1057.

https://doi.org/10.1182/blood.V110.11.1057.1057

Published: 2007

Journal Articles

Effects of Cord Blood Cell Subset Populations in the Development of the Dominant Cord Blood Unit in Non-Myeloablative Sequential Double Cord Blood Transplantation (DCBT).

David T. Ting, MD, Karen Ballen, MD, Thomas R. Spitzer, MD, Richard L. Haspel, MD, Michelle Dorn, Fred Preffer, PhD, Vassiliki Boussiotis, MD PhD, Steven McAfee, MD, Eyal Attar, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, Corey Cutler, MD MPH, Vincent Ho, MD, Bimalangshu R. Dey, MD

Blood (2006) 108 (11): 3148.

https://doi.org/10.1182/blood.V108.11.3148.3148

Published: 2006

Journal Articles

Nucleotide Receptor P2Y14 Modulates Hematopoietic Stem Cell Response to Tissue Injury Altering Stem Cell Preservation and Tissue Recovery.

Yoriko Saito, MD, Eyal Attar, MD, Samyukta Jana, BS, David Dombkowski, BS, Viktor Janzen, MD, Byeong-Chel Lee, PhD, Alastair D. Morrison, PhD, Alejandro Abuin, PhD, Sue Pickering, PhD, George P. Livi, PhD, Gregor B. Adams, PhD, David T. Scadden, MD

Blood (2006) 108 (11): 679.

https://doi.org/10.1182/blood.V108.11.679.679

Published: 2006

Journal Articles

Outcomes of 40 Adult Patients after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Conditioning Regimen.

Karen K. Ballen, MD, Corey Cutler, MD, Thomas R. Spitzer, MD, Beow Yeap, ScD, Steve McAfee, MD, Bimalangshu R. Dey, MD, Eyal Attar, MD, Richard L. Haspel, MD, PhD, Edwin Alyea, MD, Vincent Ho, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD

Blood (2006) 108 (11): 605.

https://doi.org/10.1182/blood.V108.11.605.605

Published: 2006

Journal Articles

Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

David T. Ting, MD, Bimalangshu Dey, MD, Ahmed Chaudhary, Christine Colby, Karen Power, Steven McAfee, MD, Karen Ballen, MD, Eyal Attar, MD, Susan Saidman, Frederick Preffer, Robert Sackstein, MD, PhD, Juanita Shaffer, Megan Sykes, MD, Thomas R. Spitzer, MD

Blood (2005) 106 (11): 3665.

https://doi.org/10.1182/blood.V106.11.3665.3665

Published: 2005

Journal Articles

In Vivo and Ex Vivo T-Cell Depleted (TCD) NonmyeloablativeHaploidentical Stem Cell Transplantation (NSCT) for Hematologic Malignancy (HM).

Thomas R. Spitzer, MD, Steven L. McAfee, MD, Dey R. Bimalangshu, MD, Karen Ballen, MD, Eyal Attar, MD, Christine Colby, PharmD, Fred Preffer, PhD, Susan Saidman, PhD, Juanita Shaffer, David H. Sachs, MD, Megan Sykes, MD

Blood (2005) 106 (11): 5431.

https://doi.org/10.1182/blood.V106.11.5431.5431

Published: 2005

Journal Articles

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

Karen K. Ballen, MD, Thomas R. Spitzer, MD, Beow Yeap, ScD, McAfee Steve, MD, Bimalanghsu R. Dey, MD, Eyal Attar, MD, Edwin Alyea, MD, Corey Cutler, MD, Vincent Ho, MD, Stephanie Lee, MD, Robert Soiffer, MD, Joseph H. Antin, MD

Blood (2005) 106 (11): 2048.

https://doi.org/10.1182/blood.V106.11.2048.2048

Published: 2005

Journal Articles

Parathyroid Hormone May Improve Autologous Stem Cell Mobilization Via the Stem Cell Niche.

Karen K. Ballen, MD, Elizabeth J. Shpall, MD, David Avigan, MD, Beow Yeap, ScD, Steve McAfee, MD, Bimalangshu R. Dey, MD, Eyal Attar, MD, Henry Kronenberg, MD, Joseph H. Antin, MD, Thomas R. Spitzer, MD

Blood (2005) 106 (11): 1968.

https://doi.org/10.1182/blood.V106.11.1968.1968

Published: 2005

NARROW

A Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117

Dasatinib Has Activity in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL/SLL), a Phase II Trial

Development of CMV-SPECIFIC Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of NAÏVE CD8+ T Cells

Restoration of Bone Balance Via Activin a Inhibition Results in Anti-Myeloma Activity

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Cardiac Transplant Followed by High-Dose Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients with AL Amyloidosis and Severe Heart Failure.

Identification of RPS14 as the 5q-Syndrome Gene by RNA Interference Screen.

The Type of Upfront Induction Therapy for Newly Diagnosed Multiple Myeloma Patients Has No Significant Impact on Clinical Outcomes after Autologous Hematopoietic Stem Cell Transplantation.

Non-Myeloablative T-Cell Depleted (TCD) Haploidentical Hematopoietic Cell Transplantation (HCT) Followed by Donor Leukocyte Infusion(s) for Hematologic Malignancies: The MGH Experience.

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

Effects of Cord Blood Cell Subset Populations in the Development of the Dominant Cord Blood Unit in Non-Myeloablative Sequential Double Cord Blood Transplantation (DCBT).

Nucleotide Receptor P2Y14 Modulates Hematopoietic Stem Cell Response to Tissue Injury Altering Stem Cell Preservation and Tissue Recovery.

Outcomes of 40 Adult Patients after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Conditioning Regimen.

Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

In Vivo and Ex Vivo T-Cell Depleted (TCD) NonmyeloablativeHaploidentical Stem Cell Transplantation (NSCT) for Hematologic Malignancy (HM).

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

Parathyroid Hormone May Improve Autologous Stem Cell Mobilization Via the Stem Cell Niche.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only